Full-Time
Social Media Graphic Designer
Posted on 8/19/2025
Pattern Bioscience
51-200 employees
AI-driven rapid bacterial ID and AST
No salary listed
Pune, Maharashtra, India
Hybrid
 Social Media (2) |
|---|
| , |
- Bachelor's degree in Graphic Design, Visual Arts, or related field.
- Proven experience (2+ years) in graphic design for social media, preferably in an agency or digital marketing environment.
- Proficiency in Adobe Creative Suite (Photoshop, Illustrator, InDesign) and other graphic design tools.
- Strong understanding of typography, colour theory, and layout principles.
- Experience with motion graphics and video editing software is a plus.
- Knowledge of current trends in social media design and digital marketing.
- Excellent communication skills and ability to present and defend creative ideas.
- Ability to manage multiple projects and deadlines simultaneously.
- A portfolio that demonstrates creative thinking and proficiency in graphic design for social media.
- Design visually striking graphics, illustrations, and layouts for social media posts, ads, and campaigns.
- Ensure all design elements align with brand guidelines and messaging strategies.
- Collaborate with copywriters and marketing team members to brainstorm creative concepts.
- Develop engaging multimedia content (such as videos, GIFs, infographics) for various social media platforms.
- Adapt designs for different formats and optimize them for maximum impact and usability.
- Work closely with the social media team to align visual design with overall content strategy and campaign goals.
- Communicate effectively with stakeholders to understand project requirements and expectations.
- Creativity and innovation – consistently delivers fresh ideas and designs that captivate audiences.
- Attention to detail – does not let important details slip through the cracks or derail a project.
- Efficiency – able to produce significant output with minimal wasted effort.
- Proactivity – acts without being told what to do and brings new ideas to the company.
- Intelligence – learns quickly and demonstrates an ability to quickly and proficiently understand and absorb new information.
- Flexibility/adaptability – adjust quickly to changing priorities and conditions and copes effectively with complexity and change.
- Enthusiasm – Exhibits passion and excitement over work and has a can-do attitude.
- Communication – Speaks and writes clearly and articulately without being overly verbose or talkative. Maintains this standard in all forms of written communication, including email.
- Teamwork – reaches out to all peers and cooperates with supervisors to establish an overall collaborative working relationship.
- Organization & planning – plans, organizes and creates in an efficient, productive manner.
Pattern Bioscience develops rapid clinical diagnostics that identify bacterial infections and determine antibiotic resistance. Its system uses single-cell analysis with AI pattern recognition to deliver definitive ID/AST results in about four hours. The product suite includes diagnostic devices, consumables, service contracts, and software for AI analysis. By speeding and improving accuracy, Pattern Bioscience aims to help hospitals reduce inappropriate antibiotic use and combat antibiotic resistance.
Company Size
51-200
Company Stage
Series D
Total Funding
$91.6M
Headquarters
Austin, Texas
Founded
2016
Simplify's Take
What believers are saying
- $43M Series D funding from AMR Action Fund supports FDA 510(k) submission.
- $40.9M BARDA contract accelerates pneumonia and bacteremia panel development.
- Over 1,000 samples enrolled in multi-center trial for Q3 regulatory push.
What critics are saying
- Accelerate Diagnostics' PhenoVue captures market with FDA-cleared 3-hour AST.
- BioFire's FilmArray dominates ICU syndromic testing, sidelining single-pathogen focus.
- Clinical trial failure by mid-2026 exhausts Series D runway, halting launch.
What makes Pattern Bioscience unique
- Digital CultureTM enables culture-free phenotypic ID/AST in four hours.
- Single-cell analysis captures all resistance mechanisms unlike genotypic tests.
- Pneumonia ID/AST Panel targets critically ill patients with FDA Breakthrough Designation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
Paid Holidays
401(k) Company Match
401(k) Retirement Plan
Health Savings Account/Flexible Spending Account
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 2%2 year growth
↓ -1%Pattern Bioscience has raised $43 million in Series D funding, led by AMR Action Fund, Illumina Ventures, and Omnimed Capital. The funds will support a US multi-center clinical trial and regulatory submission for their Pneumonia ID/AST Panel, which has FDA Breakthrough Device Designation and is backed by a BARDA contract worth up to $40.9 million. Latham & Watkins LLP represented Pattern Bioscience in the transaction.
To quickly develop effective treatments for drug-resistant bacterial infections, Pattern is a leader in the application of single-cell microbiology.
Pattern Bioscience secures $28.7 million in Series C financing to accelerate development of first-of-its-kind infectious disease diagnostic platform
Pattern Bioscience, an Austin, TX-based company which specializes in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, raised $28.7M in Series C funding.
Including the Series C round, Pattern has now raised $68 million to date, the company said in a statement.